[BIOSTAR PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS XIANYANG, China, May 17, 2010 (Xinhua-PRNewswire-FirstCall) - Q1 2010 revenue increased 66.0% to $12.4 million - Q1 gross margins were 77.0%, a 1,270-basis point improvement - Q1 2010 Non-GAAP adjusted net income increased 32.1% to $2.4 million with adjusted EPS of $0.09 - Biostar reiterates guidance for 2010: Revenue expected to]
[BIOSTAR PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS XIANYANG, China, May 17, 2010 (Xinhua-PRNewswire-FirstCall) - Q1 2010 revenue increased 66.0% to $12.4 million - Q1 gross margins were 77.0%, a 1,270-basis point improvement - Q1 2010 Non-GAAP adjusted net income increased 32.1% to $2.4 million with adjusted EPS of $0.09 - Biostar reiterates guidance for 2010: Revenue expected to]
[THT HEAT TRANSFER TECHNOLOGY ANNOUNCES First quarter sales revenue increased by 141.4% year-over-year; SIPING, CHINA May 17, 2010 THT Heat Transfer Technology, Inc. (OTCBB:THTI, the Company, or THT), a leading provider of heat exchangers and heat exchange solutions in Chinas clean technology industry, today announced its unaudited financial results for the first quarter ended March 31, 2010. First] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 17, 2010 THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 000-52232 20-5463509 (State or other jurisdiction of incorporation (IRS Employer Identification No.) or organization) THT Industrial Park No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People's Republic of China 86-434-3265241 _______________________________________________________ see ITEM 2.02. RESULTS OF OPERATIONS AND]
[THT HEAT TRANSFER TECHNOLOGY ANNOUNCES First quarter sales revenue increased by 141.4% year-over-year; SIPING, CHINA May 17, 2010 THT Heat Transfer Technology, Inc. (OTCBB:THTI, the Company, or THT), a leading provider of heat exchangers and heat exchange solutions in Chinas clean technology industry, today announced its unaudited financial results for the first quarter ended March 31, 2010. First] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 17, 2010 THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 000-52232 20-5463509 (State or other jurisdiction of incorporation (IRS Employer Identification No.) or organization) THT Industrial Park No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People's Republic of China 86-434-3265241 _______________________________________________________ see ITEM 2.02. RESULTS OF OPERATIONS AND]
[LOANOUT AGREEMENT This LOANOUT AGREEMENT (this “Agreement”), dated as of May 14, 2010 (the “Effective Date”), by and between Worldwide Officers, Inc. a California Corporation having its principal location of 6571 Morningside Drive, Huntington Beach, California 92648 (“Lender”), and China Jo-Jo Drugstores, Inc. having a principal location at Room 507-513, 5th Floor, A Building, Meidu Plaza Gongshu District, Hangzhou, Zhejiang] [INDEMNIFICATION AGREEMENT THIS AGREEMENT is entered into, effective as of May 14, 2010 by and between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and Bennet P. Tchaikovsky (“Indemnitee”). WHEREAS, it is essential to the Company to retain and attract as directors and officers the most capable persons available; WHEREAS, Indemnitee is an officer of the Company; and WHEREAS,]
[LOANOUT AGREEMENT This LOANOUT AGREEMENT (this “Agreement”), dated as of May 14, 2010 (the “Effective Date”), by and between Worldwide Officers, Inc. a California Corporation having its principal location of 6571 Morningside Drive, Huntington Beach, California 92648 (“Lender”), and China Jo-Jo Drugstores, Inc. having a principal location at Room 507-513, 5th Floor, A Building, Meidu Plaza Gongshu District, Hangzhou, Zhejiang] [INDEMNIFICATION AGREEMENT THIS AGREEMENT is entered into, effective as of May 14, 2010 by and between China Jo-Jo Drugstores, Inc., a Nevada corporation (the “Company”), and Bennet P. Tchaikovsky (“Indemnitee”). WHEREAS, it is essential to the Company to retain and attract as directors and officers the most capable persons available; WHEREAS, Indemnitee is an officer of the Company; and WHEREAS,]
[BIOSTAR PHARMACEUTICALS, ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS XIANYANG, China, May 17, 2010 (Xinhua-PRNewswire-FirstCall) - Q1 2010 revenuereased 66.0% to $12.4 million - Q1 gross margins were 77.0%, a 1,270-basis point improvement - Q1 2010 Non-GAAPjusted netomereased 32.1% to $2.4 million withjusted EPS of $0.09]
[v185365_ex99-1.htm 2 EX-99.1]
[BIOSTAR PHARMACEUTICALS, ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS XIANYANG, China, May 17, 2010 (Xinhua-PRNewswire-FirstCall) - Q1 2010 revenuereased 66.0% to $12.4 million - Q1 gross margins were 77.0%, a 1,270-basis point improvement - Q1 2010 Non-GAAPjusted netomereased 32.1% to $2.4 million withjusted EPS of $0.09]
[v185365_ex99-1.htm 2 EX-99.1]
